ConductScience.org, home

85,013 comparisons from ClinicalTrials.gov.

85,013 comparisons

Most participants first33,758 with no events in either group come last3,581 to 3,600 of 85,013

Show the results as
ComparisonWith the outcomeRisk difference, 95% intervalParticipantsTrial
Transdisciplinary Approach vs Multidisciplinary Approach: Unintended Weight Loss137 of 517

294 of 1,394

5.4 points

1.2 to 9.9

1,911NCT03442322

Optimizing Care for Patients With Dementia

Telelactation Support vs Ebook: Breastfeeding Duration 1674 of 955

639 of 956

3.7 points

-0.4 to 7.9

1,911NCT04856163

The Impact of Telelactation Services on Breastfeeding Outcomes

Telelactation Support vs Ebook: Breastfeeding Exclusivity448 of 955

422 of 956

2.8 points

-1.7 to 7.2

1,911NCT04856163

The Impact of Telelactation Services on Breastfeeding Outcomes

Data-informed Stepped Care (DiSC) Arm vs Standard of Care: deaths from any cause3 of 895

2 of 1,016

0.1 points

-0.4 to 0.8

1,911NCT05007717

Data-informed Stepped Care (DiSC) to Improve Adolescent HIV Outcomes (UH3)

Data-informed Stepped Care (DiSC) Arm vs Standard of Care: serious adverse events1 of 895

0 of 1,016

0.1 points

-0.3 to 0.6

1,911NCT05007717

Data-informed Stepped Care (DiSC) to Improve Adolescent HIV Outcomes (UH3)

PIIA: SAPIEN XT - 2 Year vs Control: SAVR - 2 Year: serious adverse events666 of 974

672 of 936

-3.4 points

-7.5 to 0.7

1,910NCT01314313

PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - XT Intermediate and High Risk

Intervention Clinic vs Control Clinic: Number of Participants Who Complete Glycemic Lab Testing Out of Those With an Order During Intervention Period800 of 873

906 of 1,037

4.3 points

1.5 to 7.0

1,910NCT05265312

Implementation and Evaluation of a Diabetes Prevention Clinical Pathway in Primary Care

Intervention Clinic vs Control Clinic: Achieve 5% or Greater Reduction in Weight Compared to Baseline49 of 873

43 of 1,037

1.5 points

-0.5 to 3.5

1,910NCT05265312

Implementation and Evaluation of a Diabetes Prevention Clinical Pathway in Primary Care

Transdisciplinary Approach vs Multidisciplinary Approach: Physical Restraints Use0 of 520

70 of 1,387

-5.0 points

-6.3 to -3.8

1,907NCT03442322

Optimizing Care for Patients With Dementia

Transdisciplinary Approach vs Multidisciplinary Approach: Falls246 of 520

614 of 1,387

3.0 points

-2.0 to 8.1

1,907NCT03442322

Optimizing Care for Patients With Dementia

Candesartan vs Placebo: Number of Participants With at Least a 3 Step Improvement or a Persistent 2-step Improvement in the ETDRS Severity Scale.180 of 951

136 of 954

4.7 points

1.3 to 8.0

1,905NCT00252694

DIabetic Retinopathy Candesartan Trials

Candesartan vs Placebo: Number of Participants With a 3-step or Greater Increase in Early Treatment of Diabetic Retinopathy Study (EDTRS) Severity Scale161 of 951

182 of 954

-2.1 points

-5.6 to 1.3

1,905NCT00252694

DIabetic Retinopathy Candesartan Trials

Candesartan vs Placebo: Number of Participants With Incident Clinically Significant Macular Edema (CSME) and/or Proliferative Diabetic Retinopathy (PDR).192 of 951

193 of 954

-0.0 points

-3.6 to 3.6

1,905NCT00252694

DIabetic Retinopathy Candesartan Trials

Candesartan vs Placebo: Number of Participants With a 3-step or Greater Increase in Early Treatment of Diabetic Retinopathy Study (EDTRS) Severity Scale127 of 951

124 of 954

0.4 points

-2.7 to 3.4

1,905NCT00252720

DIabetic Retinopathy Candesartan Trials.

Candesartan vs Placebo: Number of Participants With Incident Clinically Significant Macular Edema (CSME) and/or Proliferative Diabetic Retinopathy (PDR).110 of 951

107 of 954

0.4 points

-2.5 to 3.2

1,905NCT00252720

DIabetic Retinopathy Candesartan Trials.

Candesartan vs Placebo: Number of Participants With a Regression of Diabetic Retinopathy.140 of 951

139 of 954

0.2 points

-3.0 to 3.3

1,905NCT00252720

DIabetic Retinopathy Candesartan Trials.

Percutaneous Coronary Intervention (PCI) vs Coronary Artery Bypass Graft (CABG): Number of Participants With All-cause Death, Protocol Defined MI or Protocol Defined Stroke46 of 948

75 of 957

-3.0 points

-5.2 to -0.8

1,905NCT01205776

EXCEL Clinical Trial

Percutaneous Coronary Intervention (PCI) vs Coronary Artery Bypass Graft (CABG): Number of Participants With Bleeding Academic Research Consortium (BARC) Bleeding109 of 948

145 of 957

-3.7 points

-6.7 to -0.6

1,905NCT01205776

EXCEL Clinical Trial

Percutaneous Coronary Intervention (PCI) vs Coronary Artery Bypass Graft (CABG): Number of Participants With All-cause Mortality (Cardiac Death and Non-cardiac Death)9 of 948

10 of 957

-0.1 points

-1.1 to 0.9

1,905NCT01205776

EXCEL Clinical Trial

Percutaneous Coronary Intervention (PCI) vs Coronary Artery Bypass Graft (CABG): Number of Participants With Bleeding Academic Research Consortium (BARC) Bleeding112 of 948

147 of 957

-3.5 points

-6.6 to -0.5

1,905NCT01205776

EXCEL Clinical Trial

Request

GET /api/comparisons/v1

Words from a trial's title, conditions or interventions, its outcome or its groups, or an NCT number.

An outcome counted in participants, the serious adverse events, or the deaths from any cause.

No key needed

Code

Show the call in
curl "https://conductscience.org/api/comparisons/v1?page=180"

Response

The first 2 of this page's 20 results. GET /api/comparisons/v1?page=180

{
  "data": {
    "total": 85013,
    "results": [
      {
        "id": "NCT03442322-0f9b5a75",
        "title": "Transdisciplinary Approach vs Multidisciplinary Approach: Unintended Weight Loss",
        "summary": "137 of 517 against 294 of 1394; risk difference 5.4 points, 95% interval 1.2 to 9.9; NCT03442322, Optimizing Care for Patients With Dementia",
        "record": "/library/comparisons/NCT03442322-0f9b5a75",
        "nct_id": "NCT03442322",
        "kind": "outcome",
        "participants": 1911,
        "risk_difference": {
          "value": 0.054086455075496226,
          "lower": 0.01161730141455098,
          "upper": 0.09879300060470116
        },
        "group_1": "137 of 517",
        "group_2": "294 of 1,394",
        "difference": "5.4 points",
        "interval": "1.2 to 9.9",
        "trial_title": "Optimizing Care for Patients With Dementia"
      },
      {
        "id": "NCT04856163-861a4218",
        "title": "Telelactation Support vs Ebook: Breastfeeding Duration 1",
        "summary": "674 of 955 against 639 of 956; risk difference 3.7 points, 95% interval -0.4 to 7.9; NCT04856163, The Impact of Telelactation Services on Breastfeeding Outcomes",
        "record": "/library/comparisons/NCT04856163-861a4218",
        "nct_id": "NCT04856163",
        "kind": "outcome",
        "participants": 1911,
        "risk_difference": {
          "value": 0.0373491204626607,
          "lower": -0.0042284110275502065,
          "upper": 0.07874791008109633
        },
        "group_1": "674 of 955",
        "group_2": "639 of 956",
        "difference": "3.7 points",
        "interval": "-0.4 to 7.9",
        "trial_title": "The Impact of Telelactation Services on Breastfeeding Outcomes"
      }
    ],
    "no_events": 33758,
    "columns": [
      {
        "key": "title",
        "label": "Comparison"
      },
      {
        "key": "group_1",
        "label": "With the outcome",
        "under": "group_2"
      },
      {
        "key": "difference",
        "label": "Risk difference, 95% interval",
        "under": "interval"
      },
      {
        "key": "participants",
        "label": "Participants"
      },
      {
        "key": "nct_id",
        "label": "Trial",
        "under": "trial_title"
      }
    ],
    "order": "Most participants first",
    "kinds": {
      "all": 85013,
      "outcome": 33568,
      "serious-adverse-events": 31897,
      "deaths": 19548
    }
  },
  "release": "trial-comparisons-2026-03-23-0.1.0",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "No license stated"
    }
  ],
  "next": "/api/comparisons/v1?page=181",
  "request_id": "54YlvMwieKx3g8P4"
}

Ask about these results. The first 10 go in the prompt.

About this data
Holds
85,013 comparisons
From ClinicalTrials.gov. Counted 10 Nov 2026.
Release
23 Mar 2026
trial-comparisons-2026-03-23-0.1.0
Checked
20 of 20 review comparisons traced to ClinicalTrials.gov, and all 510,078 numbers calculated again apart from the builder agree
Access
Open
No account. 60 calls a minute from one address.

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

Genes

NCBI Gene

One gene with its proteins, patents, drugs, trials, grants and papers.

Trials

ClinicalTrials.gov

Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.

Sequences

Patent publications

Paste a sequence and see the patents that disclose it.

Opens sequences.conductscience.org

For software

Read Trial comparisons from software.

Every answer on this page is also JSON, under /api/comparisons/v1. No key.

GET https://conductscience.org/api/comparisons/v1?q=placebo%20heart%20failure&kind=outcome

Ask an assistant

  • In FOURIER, how did serious adverse events compare between evolocumab and placebo?
  • Which metformin trials reported deaths, and what was the risk difference?
  • What was the number needed to treat for HELIOS-B's composite outcome?
  • Which placebo-controlled heart failure trials had the most participants?